CD8A and neoplasm: Although it has been repeatedly demonstrated that MDSCs modulate the CD8+ T response by activating regulatory T cells while inhibiting effector T cells, and that macrophages respond to pro-tumor chemokines directing their polarization to M2 macrophages, including subsets of tumor-associated macrophages (TAMs), most dysregulation occurs in the lymphoid compartment (54, 94–98).